<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> has been a near universal <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> for cardiac surgery; however it is contraindicated in <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> type II </plain></SENT>
<SENT sid="1" pm="."><plain>Alternative <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> such as bivalirudin (a direct thrombin inhibitor) are being utilized </plain></SENT>
<SENT sid="2" pm="."><plain>Bivalirudin was successfully used in an immunologically complex patient (diagnoses of <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> type II, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, and dialysis-dependent <z:hpo ids='HP_0000083'>renal failure</z:hpo>) requiring cardiopulmonary bypass </plain></SENT>
<SENT sid="3" pm="."><plain>Thrombotic events are common in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> patients undergoing cardiac surgery utilizing high-dose <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>This may represent unrecognized <z:hpo ids='HP_0011874'>heparin-induced thrombocytopenia</z:hpo> type II </plain></SENT>
<SENT sid="5" pm="."><plain>Our patient did not experience perioperative thrombotic or <z:mp ids='MP_0001914'>bleeding</z:mp> complications </plain></SENT>
<SENT sid="6" pm="."><plain>The possible cross-reactivity between <z:hpo ids='HP_0011874'>heparin induced thrombocytopenia</z:hpo> type II and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> has not been investigated </plain></SENT>
</text></document>